VanEck Pharmaceutical ETF (PPH US) stock market data APIs
106.5593
-0.72(-0.7%)
as of January 7, 2026
Try our APIs with
free plan!
VanEck Pharmaceutical ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
106.5593
Open
105.8434
High
108.3059
Low
105.2572
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get VanEck Pharmaceutical ETF data using free add-ons & libraries
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
VanEck Pharmaceutical ETF News
New
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fund launched on...
Spotlight on Health ETFs as NVO & LLY Cut Obesity Drug Price in China
Recent reports suggesting that pharma giants Novo Nordisk NVO and Eli Lilly LLY have lowered prices for their blockbuster obesity drugs, Wegovy and Mounjaro, in China, have sent ripples through the he...
The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug
The recent U.S. Food and Drug Administration (FDA) approval of Novo Nordisk’s NVO oral obesity pill, Wegovy, marks a significant turning point in the fiercely competitive weight-loss drug market. Th...
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
The Invesco Pharmaceuticals ETF (PJP) was launched on June 23, 2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity m...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
